| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.876 | 0.004 | 0.876 | Caspase 9 stimulant | 0.854 0.005 DBMET00253 | ||
| 0.857 | 0.004 | 0.857 | Aldehyde oxidase inhibitor | 0.828 0.004 DBMET00253 | ||
| 0.81 | 0.002 | 0.81 | Melanin inhibitor | 0.782 0.002 DBMET00253 | ||
| 0.81 | 0.003 | 0.81 | Monophenol monooxygenase inhibitor | 0.796 0.003 DBMET00253 | ||
| 0.809 | 0.004 | 0.856 | Antioxidant | 0.856 0.004 DBMET00253 | DBMET00253 | |
| 0.812 | 0.015 | 0.824 | Apoptosis agonist | 0.824 0.014 DBMET00253 | DBMET00253 | |
| 0.783 | 0.004 | 0.818 | Free radical scavenger | 0.818 0.004 DBMET00253 | DBMET00253 | |
| 0.791 | 0.019 | 0.791 | Alpha-glucosidase inhibitor | 0.754 0.025 DBMET00253 | ||
| 0.775 | 0.004 | 0.79 | Amyloid beta aggregation inhibitor | 0.79 0.004 DBMET00253 | DBMET00253 | |
| 0.774 | 0.004 | 0.779 | Caspase 3 stimulant | 0.779 0.004 DBMET00253 | DBMET00253 | |
| 0.766 | 0.002 | 0.766 | Amylase inhibitor | 0.752 0.003 DBMET00253 | ||
| 0.743 | 0.002 | 0.787 | Cystathionine beta-synthase inhibitor | 0.787 0.002 DBMET00253 | DBMET00253 | |
| 0.747 | 0.016 | 0.747 | Transcription factor NF kappa B inhibitor | 0.71 0.019 DBMET00253 | ||
| 0.714 | 0.005 | 0.714 | Antiamyloidogenic | 0.652 0.005 DBMET00253 | ||
| 0.718 | 0.011 | 0.718 | 15-Lipoxygenase inhibitor | 0.701 0.013 DBMET00253 | ||
| 0.709 | 0.005 | 0.709 | Lipoxygenase inhibitor | 0.674 0.006 DBMET00253 | ||
| 0.697 | 0.005 | 0.736 | Histamine release inhibitor | 0.736 0.004 DBMET00253 | DBMET00253 | |
| 0.717 | 0.028 | 0.77 | Antiinflammatory | 0.77 0.019 DBMET00253 | DBMET00253 | |
| 0.663 | 0.001 | 0.705 | Histidine decarboxylase inhibitor | 0.705 0.001 DBMET00253 | DBMET00253 | |
| 0.652 | 0.005 | 0.652 | Hypoxia-inducible factor 1 alpha inhibitor | 0.606 0.007 DBMET00253 | ||
| 0.647 | 0.003 | 0.647 | Beta glucuronidase inhibitor | 0.635 0.003 DBMET00253 | ||
| 0.643 | 0.005 | 0.663 | MAO inhibitor | 0.663 0.004 DBMET00253 | DBMET00253 | |
| 0.609 | 0.003 | 0.634 | Xanthine oxidase inhibitor | 0.634 0.003 DBMET00253 | DBMET00253 | |
| 0.593 | 0.004 | 0.593 | Breast cancer-resistant protein inhibitor | 0.548 0.004 DBMET00253 | ||
| 0.585 | 0.003 | 0.725 | Estrogen receptor alpha antagonist | 0.725 0.002 DBMET00253 | DBMET00253 | |
| 0.589 | 0.014 | 0.589 | Spasmolytic | 0.581 0.015 DBMET00253 | ||
| 0.578 | 0.003 | 0.703 | Estrogen receptor beta antagonist | 0.703 0.003 DBMET00253 | DBMET00253 | |
| 0.571 | 0.005 | 0.646 | Peroxidase inhibitor | 0.646 0.004 DBMET00253 | DBMET00253 | |
| 0.574 | 0.011 | 0.616 | Nitric oxide antagonist | 0.616 0.009 DBMET00253 | DBMET00253 | |
| 0.56 | 0.011 | 0.607 | Hypoglycemic | 0.607 0.008 DBMET00253 | DBMET00253 | |
| 0.55 | 0.004 | 0.692 | Estrogen antagonist | 0.692 0.003 DBMET00253 | DBMET00253 | |
| 0.558 | 0.014 | 0.593 | Apoptosis antagonist | 0.593 0.01 DBMET00253 | DBMET00253 | |
| 0.543 | 0.002 | 0.778 | Creatine kinase inhibitor | 0.778 0.001 DBMET00253 | DBMET00253 | |
| 0.546 | 0.01 | 0.546 | Tumour necrosis factor alpha release inhibitor | 0.501 0.014 DBMET00253 | ||
| 0.536 | 0.004 | 0.546 | 5 Hydroxytryptamine uptake stimulant | 0.546 0.004 DBMET00253 | DBMET00253 | |
| 0.537 | 0.018 | 0.537 | 12-Lipoxygenase inhibitor | 0.477 0.024 DBMET00253 | ||
| 0.52 | 0.005 | 0.554 | MAO B inhibitor | 0.554 0.005 DBMET00253 | DBMET00253 | |
| 0.502 | 0.007 | 0.548 | Hepatoprotectant | 0.548 0.005 DBMET00253 | DBMET00253 | |
| 0.535 | 0.041 | 0.643 | Cyclophilin D inhibitor | 0.643 0.02 DBMET00253 | DBMET00253 | |
| 0.494 | 0.004 | 0.494 | Expectorant | 0.392 0.005 DBMET00253 | ||
| 0.491 | 0.013 | 0.516 | Vasodilator | 0.516 0.011 DBMET00253 | DBMET00253 | |
| 0.481 | 0.004 | 0.516 | Neurotrophic factor enhancer | 0.516 0.004 DBMET00253 | DBMET00253 | |
| 0.479 | 0.005 | 0.484 | Acetylcholinesterase inhibitor | 0.484 0.005 DBMET00253 | DBMET00253 | |
| 0.471 | 0.003 | 0.471 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.459 0.003 DBMET00253 | ||
| 0.467 | 0.004 | 0.519 | Aromatase inhibitor | 0.519 0.003 DBMET00253 | DBMET00253 | |
| 0.469 | 0.009 | 0.469 | Tubulin antagonist | 0.311 0.018 DBMET00253 | ||
| 0.466 | 0.01 | 0.466 | P-glycoprotein inhibitor | 0.422 0.014 DBMET00253 | ||
| 0.491 | 0.043 | 0.525 | Antibacterial | 0.525 0.034 DBMET00253 | DBMET00253 | |
| 0.447 | 0.007 | 0.484 | Lipid peroxidase inhibitor | 0.484 0.005 DBMET00253 | DBMET00253 | |
| 0.455 | 0.017 | 0.455 | Antimitotic | 0.348 0.033 DBMET00253 | ||
| 0.441 | 0.004 | 0.54 | Estrogen agonist | 0.54 0.003 DBMET00253 | DBMET00253 | |
| 0.438 | 0.005 | 0.438 | NADPH oxidase inhibitor | 0.372 0.005 DBMET00253 | ||
| 0.436 | 0.004 | 0.468 | Carbonic anhydrase III inhibitor | 0.468 0.003 DBMET00253 | DBMET00253 | |
| 0.433 | 0.003 | 0.539 | Estrogen receptor beta agonist | 0.539 0.002 DBMET00253 | DBMET00253 | |
| 0.423 | 0.007 | 0.521 | NOS3 expression enhancer | 0.521 0.005 DBMET00253 | DBMET00253 | |
| 0.414 | 0.003 | 0.414 | Mucolytic | 0.348 0.004 DBMET00253 | ||
| 0.43 | 0.022 | 0.43 | DNA damaging | 0.396 0.029 DBMET00253 | ||
| 0.411 | 0.004 | 0.411 | Cholesterol synthesis inhibitor | 0.401 0.004 DBMET00253 | ||
| 0.445 | 0.043 | 0.592 | GABA C receptor rho-3 antagonist | 0.592 0.008 DBMET00253 | DBMET00253 | |
| 0.44 | 0.038 | 0.44 | 5 Hydroxytryptamine release stimulant | 0.412 0.043 DBMET00253 | ||
| 0.407 | 0.009 | 0.415 | Cholinergic | 0.415 0.009 DBMET00253 | DBMET00253 | |
| 0.389 | 0.009 | 0.4 | MAO A inhibitor | 0.4 0.009 DBMET00253 | DBMET00253 | |
| 0.386 | 0.009 | 0.386 | Protein kinase stimulant | 0.378 0.01 DBMET00253 | ||
| 0.385 | 0.011 | 0.407 | Topoisomerase II inhibitor | 0.407 0.01 DBMET00253 | DBMET00253 | |
| 0.397 | 0.027 | 0.397 | Superoxide dismutase inhibitor | 0.329 0.042 DBMET00253 | ||
| 0.373 | 0.004 | 0.373 | Nitric-oxide synthase stimulant | 0.372 0.004 DBMET00253 | ||
| 0.361 | 0.005 | 0.369 | Carbonic anhydrase XV inhibitor | 0.369 0.005 DBMET00253 | DBMET00253 | |
| 0.374 | 0.021 | 0.409 | RNA-directed DNA polymerase inhibitor | 0.409 0.017 DBMET00253 | DBMET00253 | |
| 0.35 | 0.005 | 0.35 | Carbonic anhydrase VI inhibitor | 0.349 0.005 DBMET00253 | ||
| 0.352 | 0.007 | 0.352 | Alkaline phosphatase inhibitor | 0.335 0.008 DBMET00253 | ||
| 0.406 | 0.074 | 0.431 | 5 Hydroxytryptamine release inhibitor | 0.431 0.061 DBMET00253 | DBMET00253 | |
| 0.337 | 0.005 | 0.355 | Topoisomerase II alpha inhibitor | 0.355 0.005 DBMET00253 | DBMET00253 | |
| 0.344 | 0.013 | 0.41 | Protein-tyrosine phosphatase inhibitor | 0.41 0.008 DBMET00253 | DBMET00253 | |
| 0.352 | 0.025 | 0.352 | Cyclic AMP phosphodiesterase inhibitor | 0.318 0.035 DBMET00253 | ||
| 0.328 | 0.009 | 0.362 | M18 aspartyl aminopeptidase inhibitor | 0.362 0.007 DBMET00253 | DBMET00253 | |
| 0.339 | 0.022 | 0.344 | Platelet adhesion inhibitor | 0.344 0.021 DBMET00253 | DBMET00253 | |
| 0.316 | 0.003 | 0.318 | Carbonic anhydrase VII inhibitor | 0.318 0.003 DBMET00253 | DBMET00253 | |
| 0.362 | 0.05 | 0.362 | Vasodilator, coronary | 0.319 0.073 DBMET00253 | ||
| 0.318 | 0.012 | 0.318 | Alkylator | 0.301 0.013 DBMET00253 | ||
| 0.315 | 0.009 | 0.346 | 5-Lipoxygenase inhibitor | 0.346 0.007 DBMET00253 | DBMET00253 | |
| 0.323 | 0.017 | 0.323 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.322 0.018 DBMET00253 | ||
| 0.322 | 0.025 | 0.349 | Dual specificity phosphatase 3 inhibitor | 0.349 0.021 DBMET00253 | DBMET00253 | |
| 0.307 | 0.01 | 0.371 | Protein-tyrosine phosphatase 1B inhibitor | 0.371 0.006 DBMET00253 | DBMET00253 | |
| 0.303 | 0.008 | 0.334 | Interleukin 4 antagonist | 0.334 0.007 DBMET00253 | DBMET00253 | |
| 0.313 | 0.027 | 0.349 | Dual specificity phosphatase inhibitor | 0.349 0.021 DBMET00253 | DBMET00253 | |
| 0.309 | 0.023 | 0.309 | DNA methyltransferase I inhibitor | 0.254 0.045 DBMET00253 | ||
| 0.284 | 0.006 | 0.284 | Carbonic anhydrase XIII inhibitor | 0.249 0.009 DBMET00253 | ||
| 0.275 | 0.004 | 0.294 | Estradiol 17 beta-dehydrogenase inhibitor | 0.294 0.003 DBMET00253 | DBMET00253 | |
| 0.286 | 0.021 | 0.286 | Tumour necrosis factor antagonist | 0.191 0.059 DBMET00253 | ||
| 0.268 | 0.004 | 0.269 | Multidrug resistance-associated protein 1 inhibitor | 0.269 0.004 DBMET00253 | DBMET00253 | |
| 0.266 | 0.005 | 0.266 | Alpha tubulin antagonist | 0.205 0.006 DBMET00253 | ||
| 0.278 | 0.017 | 0.299 | Cyclooxygenase 1 inhibitor | 0.299 0.014 DBMET00253 | DBMET00253 | |
| 0.264 | 0.004 | 0.344 | Estrogen receptor alpha agonist | 0.344 0.003 DBMET00253 | DBMET00253 | |
| 0.263 | 0.017 | 0.263 | Heat shock protein 90 antagonist | 0.253 0.02 DBMET00253 | ||
| 0.263 | 0.018 | 0.267 | Succinate dehydrogenase inhibitor | 0.267 0.017 DBMET00253 | DBMET00253 | |
| 0.277 | 0.036 | 0.277 | DNA methylase inhibitor | 0.224 0.064 DBMET00253 | ||
| 0.255 | 0.016 | 0.262 | Topoisomerase I inhibitor | 0.262 0.015 DBMET00253 | DBMET00253 | |
| 0.254 | 0.016 | 0.301 | Chelator | 0.301 0.011 DBMET00253 | DBMET00253 | |
| 0.285 | 0.047 | 0.315 | Psychostimulant | 0.315 0.039 DBMET00253 | DBMET00253 | |
| 0.244 | 0.01 | 0.292 | Androgen antagonist | 0.292 0.007 DBMET00253 | DBMET00253 | |
| 0.242 | 0.013 | 0.253 | GABA C receptor rho-2 antagonist | 0.253 0.011 DBMET00253 | DBMET00253 | |
| 0.249 | 0.023 | 0.271 | Interleukin 6 antagonist | 0.271 0.019 DBMET00253 | DBMET00253 | |
| 0.233 | 0.011 | 0.233 | Cyclooxygenase 3 inhibitor | 0.226 0.012 DBMET00253 | ||
| 0.223 | 0.004 | 0.257 | Xanthine dehydrogenase inhibitor | 0.257 0.004 DBMET00253 | DBMET00253 | |
| 0.307 | 0.089 | 0.307 | Angiogenesis inhibitor | 0.246 0.126 DBMET00253 | ||
| 0.303 | 0.086 | 0.327 | Antithrombotic | 0.327 0.073 DBMET00253 | DBMET00253 | |
| 0.281 | 0.067 | 0.307 | Transcription factor STAT inhibitor | 0.307 0.052 DBMET00253 | DBMET00253 | |
| 0.219 | 0.005 | 0.27 | DOPA decarboxylase inhibitor | 0.27 0.003 DBMET00253 | DBMET00253 | |
| 0.221 | 0.007 | 0.239 | Papain-like protease (SARS coronavirus) inhibitor | 0.239 0.005 DBMET00253 | DBMET00253 | |
| 0.27 | 0.061 | 0.283 | Angiogenesis stimulant | 0.283 0.056 DBMET00253 | DBMET00253 | |
| 0.215 | 0.007 | 0.215 | Electron transport complex I inhibitor | 0.176 0.012 DBMET00253 | ||
| 0.212 | 0.007 | 0.251 | Aldose reductase inhibitor | 0.251 0.005 DBMET00253 | DBMET00253 | |
| 0.21 | 0.01 | 0.233 | AMP-activated protein kinase stimulant | 0.233 0.008 DBMET00253 | DBMET00253 | |
| 0.217 | 0.019 | 0.217 | Butyrylcholinesterase inhibitor | 0.208 0.02 DBMET00253 | ||
| 0.22 | 0.023 | 0.249 | DNA polymerase I inhibitor | 0.249 0.017 DBMET00253 | DBMET00253 | |
| 0.296 | 0.099 | 0.296 | Vasodilator, peripheral | 0.261 0.119 DBMET00253 | ||
| 0.228 | 0.033 | 0.245 | Interferon gamma antagonist | 0.245 0.029 DBMET00253 | DBMET00253 | |
| 0.306 | 0.111 | 0.328 | Immunosuppressant | 0.328 0.098 DBMET00253 | DBMET00253 | |
| 0.198 | 0.008 | 0.198 | Macrophage migration inhibitory factor inhibitor | 0.184 0.009 DBMET00253 | ||
| 0.263 | 0.074 | 0.269 | Transcription factor STAT3 inhibitor | 0.269 0.07 DBMET00253 | DBMET00253 | |
| 0.228 | 0.042 | 0.235 | Amyloid beta precursor protein antagonist | 0.235 0.039 DBMET00253 | DBMET00253 | |
| 0.189 | 0.008 | 0.189 | Beta tubulin antagonist | 0.119 0.018 DBMET00253 | ||
| 0.185 | 0.005 | 0.216 | Ornithine decarboxylase inhibitor | 0.216 0.004 DBMET00253 | DBMET00253 | |
| 0.228 | 0.049 | 0.25 | Insulin sensitizer | 0.25 0.034 DBMET00253 | DBMET00253 | |
| 0.198 | 0.02 | 0.198 | Microtubule formation inhibitor | 0.183 0.024 DBMET00253 | ||
| 0.325 | 0.15 | 0.325 | DNA directed DNA polymerase inhibitor | 0.296 0.163 DBMET00253 | ||
| 0.179 | 0.005 | 0.219 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.219 0.004 DBMET00253 | DBMET00253 | |
| 0.178 | 0.004 | 0.238 | Ca(v)3.2 blocker | 0.238 0.004 DBMET00253 | DBMET00253 | |
| 0.267 | 0.094 | 0.294 | Streptokinase A inhibitor | 0.294 0.082 DBMET00253 | DBMET00253 | |
| 0.182 | 0.013 | 0.182 | Phosphodiesterase 4D inhibitor | 0.1 0.037 DBMET00253 | ||
| 0.194 | 0.025 | 0.2 | CF transmembrane conductance regulator agonist | 0.2 0.022 DBMET00253 | DBMET00253 | |
| 0.206 | 0.039 | 0.218 | Cyclooxygenase inhibitor | 0.218 0.035 DBMET00253 | DBMET00253 | |
| 0.178 | 0.011 | 0.221 | HIV-1 integrase (3'-Processing) inhibitor | 0.221 0.008 DBMET00253 | DBMET00253 | |
| 0.242 | 0.076 | 0.284 | Tyrosine 3 hydroxylase inhibitor | 0.284 0.042 DBMET00253 | DBMET00253 | |
| 0.186 | 0.021 | 0.186 | Bronchodilator | 0.143 0.034 DBMET00253 | ||
| 0.17 | 0.005 | 0.197 | Ca(v)3.1 blocker | 0.197 0.004 DBMET00253 | DBMET00253 | |
| 0.318 | 0.155 | 0.318 | DNA polymerase beta inhibitor | 0.278 0.177 DBMET00253 | ||
| 0.231 | 0.069 | 0.258 | Interleukin antagonist | 0.258 0.059 DBMET00253 | DBMET00253 | |
| 0.162 | 0.003 | 0.202 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.202 0.003 DBMET00253 | DBMET00253 | |
| 0.182 | 0.024 | 0.202 | Antineoplastic antibiotic | 0.202 0.021 DBMET00253 | DBMET00253 | |
| 0.179 | 0.024 | 0.179 | Beta amyloid protein antagonist | 0.162 0.032 DBMET00253 | ||
| 0.214 | 0.061 | 0.214 | Non-steroidal antiinflammatory agent | 0.191 0.078 DBMET00253 | ||
| 0.222 | 0.07 | 0.222 | Pyruvate kinase inhibitor | 0.215 0.073 DBMET00253 | ||
| 0.16 | 0.009 | 0.193 | Lipase inhibitor | 0.193 0.006 DBMET00253 | DBMET00253 | |
| 0.168 | 0.018 | 0.22 | Uric acid excretion stimulant | 0.22 0.01 DBMET00253 | DBMET00253 | |
| 0.164 | 0.017 | 0.164 | Urease inhibitor | 0.164 0.017 DBMET00253 | ||
| 0.16 | 0.015 | 0.217 | Opioid kappa receptor antagonist | 0.217 0.009 DBMET00253 | DBMET00253 | |
| 0.178 | 0.035 | 0.178 | Toll-Like receptor 2 antagonist | 0.154 0.05 DBMET00253 | ||
| 0.156 | 0.013 | 0.156 | Keratolytic | 0.147 0.015 DBMET00253 | ||
| 0.171 | 0.035 | 0.186 | Proteasome inhibitor | 0.186 0.03 DBMET00253 | DBMET00253 | |
| 0.193 | 0.059 | 0.23 | Mcl-1 antagonist | 0.23 0.043 DBMET00253 | DBMET00253 | |
| 0.183 | 0.052 | 0.216 | Phospholipase A2 inhibitor | 0.216 0.035 DBMET00253 | DBMET00253 | |
| 0.149 | 0.02 | 0.157 | Protein kinase C zeta inhibitor | 0.157 0.018 DBMET00253 | DBMET00253 | |
| 0.148 | 0.022 | 0.148 | Toll-Like receptor 4 antagonist | 0.147 0.022 DBMET00253 | ||
| 0.204 | 0.078 | 0.204 | Platelet aggregation inhibitor | |||
| 0.128 | 0.003 | 0.128 | Transcription factor RelA inhibitor | 0.111 0.004 DBMET00253 | ||
| 0.157 | 0.033 | 0.158 | Heat shock protein 70 antagonist | 0.158 0.031 DBMET00253 | DBMET00253 | |
| 0.229 | 0.106 | 0.263 | Gastrin inhibitor | 0.263 0.065 DBMET00253 | DBMET00253 | |
| 0.177 | 0.057 | 0.197 | Arachidonic acid antagonist | 0.197 0.036 DBMET00253 | DBMET00253 | |
| 0.128 | 0.009 | 0.153 | Neuraminidase inhibitor | 0.153 0.005 DBMET00253 | DBMET00253 | |
| 0.136 | 0.017 | 0.136 | Dopamine D1 antagonist | 0.121 0.019 DBMET00253 | ||
| 0.163 | 0.045 | 0.173 | Cyclooxygenase 2 inhibitor | 0.173 0.041 DBMET00253 | DBMET00253 | |
| 0.14 | 0.026 | 0.174 | GABA C receptor rho-1 antagonist | 0.174 0.013 DBMET00253 | DBMET00253 | |
| 0.178 | 0.064 | 0.183 | Heat shock protein 90 alpha antagonist | 0.183 0.06 DBMET00253 | DBMET00253 | |
| 0.147 | 0.033 | 0.154 | Photosensitizer | 0.154 0.029 DBMET00253 | DBMET00253 | |
| 0.129 | 0.015 | 0.164 | HIV-1 integrase (Strand Transfer) inhibitor | 0.164 0.012 DBMET00253 | DBMET00253 | |
| 0.116 | 0.007 | 0.189 | Fatty acid synthase inhibitor | 0.189 0.004 DBMET00253 | DBMET00253 | |
| 0.137 | 0.038 | 0.192 | GABA C receptor antagonist | 0.192 0.014 DBMET00253 | DBMET00253 | |
| 0.107 | 0.009 | 0.147 | Opioid kappa receptor agonist | 0.147 0.006 DBMET00253 | DBMET00253 | |
| 0.103 | 0.005 | 0.103 | Glucose-6-phosphate translocase inhibitor | 0.097 0.007 DBMET00253 | ||
| 0.238 | 0.141 | 0.238 | Sodium/bile acid cotransporter inhibitor | 0.218 0.164 DBMET00253 | ||
| 0.114 | 0.017 | 0.128 | D-Ala-D-Ala ligase inhibitor | 0.128 0.01 DBMET00253 | DBMET00253 | |
| 0.122 | 0.028 | 0.124 | Interleukin 12 antagonist | 0.124 0.025 DBMET00253 | DBMET00253 | |
| 0.152 | 0.06 | 0.169 | Adenylate cyclase stimulant | 0.169 0.036 DBMET00253 | DBMET00253 | |
| 0.194 | 0.105 | 0.194 | Aryl hydrocarbon receptor agonist | 0.164 0.125 DBMET00253 | ||
| 0.149 | 0.06 | 0.156 | Bone formation stimulant | 0.156 0.054 DBMET00253 | DBMET00253 | |
| 0.109 | 0.021 | 0.119 | Carbonic anhydrase VA inhibitor | 0.119 0.018 DBMET00253 | DBMET00253 | |
| 0.11 | 0.024 | 0.125 | Carbonic anhydrase V inhibitor | 0.125 0.02 DBMET00253 | DBMET00253 | |
| 0.138 | 0.055 | 0.194 | Aldehyde dehydrogenase inhibitor | 0.194 0.029 DBMET00253 | DBMET00253 | |
| 0.098 | 0.017 | 0.126 | Neuraminidase (influenza) inhibitor | 0.126 0.01 DBMET00253 | DBMET00253 | |
| 0.116 | 0.035 | 0.116 | Phosphodiesterase IV inhibitor | |||
| 0.118 | 0.037 | 0.158 | Opioid antagonist | 0.158 0.023 DBMET00253 | DBMET00253 | |
| 0.131 | 0.052 | 0.131 | DNA intercalator | 0.129 0.052 DBMET00253 | ||
| 0.101 | 0.021 | 0.11 | Leukotriene antagonist | 0.11 0.018 DBMET00253 | DBMET00253 | |
| 0.187 | 0.108 | 0.187 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.155 0.137 DBMET00253 | ||
| 0.101 | 0.024 | 0.117 | HIV-1 integrase inhibitor | 0.117 0.016 DBMET00253 | DBMET00253 | |
| 0.181 | 0.105 | 0.181 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.178 0.107 DBMET00253 | ||
| 0.113 | 0.04 | 0.157 | Alcohol dehydrogenase inhibitor | 0.157 0.019 DBMET00253 | DBMET00253 | |
| 0.114 | 0.043 | 0.156 | Prolactin inhibitor | 0.156 0.02 DBMET00253 | DBMET00253 | |
| 0.115 | 0.044 | 0.146 | Anabolic | 0.146 0.02 DBMET00253 | DBMET00253 | |
| 0.115 | 0.045 | 0.131 | Protein kinase C mu inhibitor | 0.131 0.035 DBMET00253 | DBMET00253 | |
| 0.131 | 0.065 | 0.131 | Vanilloid 1 agonist | 0.113 0.106 DBMET00253 | ||
| 0.139 | 0.075 | 0.149 | Mannose-6-phosphate isomerase inhibitor | 0.149 0.065 DBMET00253 | DBMET00253 | |
| 0.086 | 0.021 | 0.109 | Protein kinase C eta inhibitor | 0.109 0.015 DBMET00253 | DBMET00253 | |
| 0.099 | 0.037 | 0.099 | Granulocyte macrophage colony stimulating factor agonist | 0.083 0.067 DBMET00253 | ||
| 0.129 | 0.069 | 0.129 | Antibacterial (Helicobacter pylori) | 0.126 0.073 DBMET00253 | ||
| 0.142 | 0.083 | 0.166 | Insulin secretagoues | 0.166 0.059 DBMET00253 | DBMET00253 | |
| 0.075 | 0.017 | 0.076 | Leukotriene B4 antagonist | 0.076 0.017 DBMET00253 | DBMET00253 | |
| 0.092 | 0.038 | 0.092 | Thioredoxin reductase inhibitor | 0.09 0.041 DBMET00253 | ||
| 0.077 | 0.024 | 0.112 | Carbonic anhydrase VB inhibitor | 0.112 0.014 DBMET00253 | DBMET00253 | |
| 0.137 | 0.084 | 0.151 | Ca2+-transporting ATPase inhibitor | 0.151 0.041 DBMET00253 | DBMET00253 | |
| 0.176 | 0.123 | 0.176 | ErbB-1 antagonist | |||
| 0.086 | 0.034 | 0.106 | Dopamine agonist | 0.106 0.025 DBMET00253 | DBMET00253 | |
| 0.091 | 0.04 | 0.105 | Na+ K+ transporting ATPase inhibitor | 0.105 0.027 DBMET00253 | DBMET00253 | |
| 0.253 | 0.202 | 0.271 | Calcium channel L-type activator | 0.271 0.184 DBMET00253 | DBMET00253 | |
| 0.055 | 0.005 | 0.067 | Estrogen-related receptor beta antagonist | 0.067 0.004 DBMET00253 | DBMET00253 | |
| 0.111 | 0.061 | 0.119 | Protein kinase C gamma inhibitor | 0.119 0.053 DBMET00253 | DBMET00253 | |
| 0.084 | 0.036 | 0.108 | Cyclin B3 inhibitor | 0.108 0.025 DBMET00253 | DBMET00253 | |
| 0.063 | 0.017 | 0.078 | Sodium/calcium exchanger inhibitor | 0.078 0.009 DBMET00253 | DBMET00253 | |
| 0.086 | 0.041 | 0.116 | Analgesic, opioid | 0.116 0.024 DBMET00253 | DBMET00253 | |
| 0.084 | 0.04 | 0.096 | Histone deacetylase stimulant | 0.096 0.031 DBMET00253 | DBMET00253 | |
| 0.084 | 0.04 | 0.096 | Histone deacetylase SIRT1 stimulant | 0.096 0.031 DBMET00253 | DBMET00253 | |
| 0.091 | 0.047 | 0.091 | Myeloperoxidase inhibitor | 0.091 0.047 DBMET00253 | ||
| 0.076 | 0.032 | 0.076 | Glutamate (mGluR7) antagonist | 0.075 0.034 DBMET00253 | ||
| 0.129 | 0.087 | 0.185 | Cell wall synthesis inhibitor | 0.185 0.037 DBMET00253 | DBMET00253 | |
| 0.095 | 0.054 | 0.095 | Thioredoxin inhibitor | 0.095 0.055 DBMET00253 | ||
| 0.062 | 0.021 | 0.067 | Topoisomerase II beta inhibitor | 0.067 0.018 DBMET00253 | DBMET00253 | |
| 0.066 | 0.025 | 0.092 | Opioid agonist | 0.092 0.015 DBMET00253 | DBMET00253 | |
| 0.176 | 0.138 | 0.218 | MAP-kinase-activated kinase 5 inhibitor | 0.218 0.084 DBMET00253 | DBMET00253 | |
| 0.047 | 0.01 | 0.047 | Tubulin agonist | 0.047 0.009 DBMET00253 | ||
| 0.103 | 0.066 | 0.109 | Mediator release inhibitor | 0.109 0.059 DBMET00253 | DBMET00253 | |
| 0.091 | 0.054 | 0.099 | Interleukin 5 antagonist | 0.099 0.043 DBMET00253 | DBMET00253 | |
| 0.173 | 0.137 | 0.227 | Immunostimulant | 0.227 0.106 DBMET00253 | DBMET00253 | |
| 0.051 | 0.015 | 0.06 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.06 0.011 DBMET00253 | DBMET00253 | |
| 0.054 | 0.019 | 0.06 | Neuraminidase (Influenza A) inhibitor | 0.06 0.013 DBMET00253 | DBMET00253 | |
| 0.125 | 0.092 | 0.137 | Farnesoid X receptor antagonist | 0.137 0.071 DBMET00253 | DBMET00253 | |
| 0.145 | 0.114 | 0.145 | Neurotensin receptor agonist | 0.139 0.133 DBMET00253 | ||
| 0.073 | 0.042 | 0.084 | Leukotriene synthesis inhibitor | 0.084 0.035 DBMET00253 | DBMET00253 | |
| 0.092 | 0.062 | 0.106 | ABCA1 expression enhancer | 0.106 0.043 DBMET00253 | DBMET00253 | |
| 0.077 | 0.047 | 0.115 | Glutamate decarboxylase inhibitor | 0.115 0.022 DBMET00253 | DBMET00253 | |
| 0.039 | 0.009 | 0.051 | Sodium/glucose cotransporter 2 inhibitor | 0.051 0.006 DBMET00253 | DBMET00253 | |
| 0.094 | 0.064 | 0.107 | Phosphodiesterase 6D inhibitor | 0.107 0.041 DBMET00253 | DBMET00253 | |
| 0.048 | 0.019 | 0.075 | Dopamine D5 agonist | 0.075 0.007 DBMET00253 | DBMET00253 | |
| 0.07 | 0.042 | 0.083 | Glucagon-like peptide 1 agonist | 0.083 0.033 DBMET00253 | DBMET00253 | |
| 0.041 | 0.013 | 0.053 | Catechol O-methyltransferase inhibitor | 0.053 0.008 DBMET00253 | DBMET00253 | |
| 0.063 | 0.035 | 0.064 | Heat shock protein 90 beta antagonist | 0.064 0.035 DBMET00253 | DBMET00253 | |
| 0.068 | 0.041 | 0.108 | Opioid delta receptor antagonist | 0.108 0.028 DBMET00253 | DBMET00253 | |
| 0.043 | 0.017 | 0.049 | Glucose-6-phosphate dehydrogenase inhibitor | 0.049 0.012 DBMET00253 | DBMET00253 | |
| 0.033 | 0.007 | 0.043 | Dopamine D1 agonist | 0.043 0.005 DBMET00253 | DBMET00253 | |
| 0.075 | 0.049 | 0.09 | CDC25A inhibitor | 0.09 0.034 DBMET00253 | DBMET00253 | |
| 0.084 | 0.059 | 0.084 | Vanilloid agonist | |||
| 0.033 | 0.009 | 0.044 | Sodium/glucose cotransporter inhibitor | 0.044 0.006 DBMET00253 | DBMET00253 | |
| 0.043 | 0.02 | 0.07 | Arginase inhibitor | 0.07 0.008 DBMET00253 | DBMET00253 | |
| 0.038 | 0.015 | 0.057 | ATP citrate lysase inhibitor | 0.057 0.005 DBMET00253 | DBMET00253 | |
| 0.049 | 0.027 | 0.065 | Dopamine D2 agonist | 0.065 0.019 DBMET00253 | DBMET00253 | |
| 0.075 | 0.053 | 0.075 | Alpha 2a adrenoreceptor antagonist | |||
| 0.052 | 0.031 | 0.052 | Carbonic anhydrase XIV inhibitor | 0.046 0.038 DBMET00253 | ||
| 0.091 | 0.07 | 0.091 | Sphingomyelinase inhibitor | |||
| 0.153 | 0.133 | 0.153 | Dyrk kinase inhibitor | 0.148 0.138 DBMET00253 | ||
| 0.053 | 0.033 | 0.053 | Vanilloid 2 antagonist | |||
| 0.07 | 0.052 | 0.1 | Telomerase inhibitor | 0.1 0.033 DBMET00253 | DBMET00253 | |
| 0.066 | 0.049 | 0.099 | Opioid mu receptor antagonist | 0.099 0.032 DBMET00253 | DBMET00253 | |
| 0.048 | 0.031 | 0.065 | Opioid mu receptor agonist | 0.065 0.021 DBMET00253 | DBMET00253 | |
| 0.084 | 0.069 | 0.084 | ATPase (Vacuolar H+) inhibitor | |||
| 0.053 | 0.038 | 0.071 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.071 0.021 DBMET00253 | DBMET00253 | |
| 0.068 | 0.053 | 0.082 | Secretase beta inhibitor | 0.082 0.033 DBMET00253 | DBMET00253 | |
| 0.058 | 0.044 | 0.058 | Ryanodine receptor antagonist | |||
| 0.049 | 0.036 | 0.069 | Squalene epoxidase inhibitor | 0.069 0.014 DBMET00253 | DBMET00253 | |
| 0.055 | 0.042 | 0.058 | Acetyl-CoA transferase 2 inhibitor | 0.058 0.036 DBMET00253 | DBMET00253 | |
| 0.059 | 0.047 | 0.059 | Transcription factor AP-1 inhibitor | 0.056 0.052 DBMET00253 | ||
| 0.071 | 0.06 | 0.071 | Phosphodiesterase VI inhibitor | |||
| 0.131 | 0.121 | 0.177 | Antipruritic | 0.177 0.067 DBMET00253 | DBMET00253 | |
| 0.148 | 0.139 | 0.192 | Hypolipemic | 0.192 0.1 DBMET00253 | DBMET00253 | |
| 0.121 | 0.112 | 0.14 | Hemostatic | 0.14 0.081 DBMET00253 | DBMET00253 | |
| 0.022 | 0.015 | 0.031 | Estrone sulfatase inhibitor | 0.031 0.01 DBMET00253 | DBMET00253 | |
| 0.118 | 0.113 | 0.141 | Thrombolytic | 0.141 0.089 DBMET00253 | DBMET00253 | |
| 0.184 | 0.18 | 0.213 | Cholesterol antagonist | 0.213 0.153 DBMET00253 | DBMET00253 | |
| 0.032 | 0.028 | 0.057 | Retinoid X alpha receptor agonist | 0.057 0.012 DBMET00253 | DBMET00253 | |
| 0.073 | 0.071 | 0.086 | MAP kinase kinase 7 inhibitor | 0.086 0.032 DBMET00253 | DBMET00253 | |
| 0.029 | 0.027 | 0.029 | Estrogen-related receptor alpha antagonist | |||
| 0.018 | 0.017 | 0.018 | Antibiotic Anthracycline-like | |||
| 0.106 | 0.106 | 0.108 | DNA repair enzyme inhibitor | 0.108 0.101 DBMET00253 | DBMET00253 | |
| 0.037 | 0.037 | 0.044 | Leukocyte elastase inhibitor | 0.044 0.028 DBMET00253 | DBMET00253 | |
| 0.078 | 0.081 | 0.123 | HIV-1 integrase (Overall Integration) inhibitor | 0.123 0.038 DBMET00253 | DBMET00253 | |
| 0.146 | 0.149 | 0.18 | Platelet antagonist | 0.18 0.117 DBMET00253 | DBMET00253 | |
| 0.039 | 0.043 | 0.045 | Microtubule stabilization | 0.045 0.035 DBMET00253 | DBMET00253 | |
| 0.117 | 0.121 | 0.12 | MAP3K9 inhibitor | 0.12 0.114 DBMET00253 | DBMET00253 | |
| 0.019 | 0.025 | 0.023 | Protein 30S ribosomal subunit inhibitor | 0.023 0.018 DBMET00253 | DBMET00253 | |
| 0.052 | 0.059 | 0.056 | Lipocortins synthesis agonist | 0.056 0.044 DBMET00253 | DBMET00253 | |
| 0.16 | 0.169 | 0.177 | Peptidyltransferase inhibitor | 0.177 0.134 DBMET00253 | DBMET00253 | |
| 0.033 | 0.042 | 0.055 | Carbonic anhydrase IV inhibitor | 0.055 0.022 DBMET00253 | DBMET00253 | |
| 0.022 | 0.031 | 0.031 | Glucocorticoid antagonist | 0.031 0.023 DBMET00253 | DBMET00253 | |
| 0.025 | 0.035 | 0.035 | Progesterone antagonist | 0.035 0.025 DBMET00253 | DBMET00253 | |
| 0.075 | 0.086 | 0.079 | Estrogen-related receptor beta agonist | 0.079 0.07 DBMET00253 | DBMET00253 | |
| 0.053 | 0.065 | 0.07 | Peroxisome proliferator-activated receptor gamma agonist | 0.07 0.049 DBMET00253 | DBMET00253 | |
| 0.069 | 0.083 | 0.079 | Inducible nitric-oxide synthase inhibitor | 0.079 0.064 DBMET00253 | DBMET00253 | |
| 0.028 | 0.042 | 0.032 | Opioid delta receptor agonist | 0.032 0.03 DBMET00253 | DBMET00253 | |
| 0.042 | 0.058 | 0.072 | Alcohol oxidase inhibitor | 0.072 0.028 DBMET00253 | DBMET00253 | |
| 0.038 | 0.054 | 0.055 | Cholesterol esterase inhibitor | 0.055 0.023 DBMET00253 | DBMET00253 | |
| 0.132 | 0.149 | 0.161 | Phospholipase C inhibitor | 0.161 0.085 DBMET00253 | DBMET00253 | |
| 0.021 | 0.043 | 0.047 | Retinoid X receptor agonist | 0.047 0.019 DBMET00253 | DBMET00253 | |
| 0.052 | 0.079 | 0.058 | Heme oxygenase stimulant | 0.058 0.054 DBMET00253 | DBMET00253 | |
| 0.03 | 0.056 | 0.049 | Carbonic anhydrase XII inhibitor | 0.049 0.039 DBMET00253 | DBMET00253 | |
| 0.07 | 0.101 | 0.093 | NADH dehydrogenase inhibitor | 0.093 0.052 DBMET00253 | DBMET00253 | |
| 0.021 | 0.052 | 0.033 | 5-Alpha-reductase inhibitor | 0.033 0.03 DBMET00253 | DBMET00253 | |
| 0.12 | 0.152 | 0.134 | MAP kinase kinase 4 inhibitor | 0.134 0.101 DBMET00253 | DBMET00253 | |
| 0.046 | 0.09 | 0.056 | Leukotriene C antagonist | 0.056 0.041 DBMET00253 | DBMET00253 | |
| 0.062 | 0.108 | 0.074 | Glutathione S-transferase inhibitor | 0.074 0.072 DBMET00253 | DBMET00253 | |
| 0.078 | 0.126 | 0.113 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.113 0.088 DBMET00253 | DBMET00253 | |
| 0.066 | 0.121 | 0.118 | UDP-glucose 4-epimerase inhibitor | 0.118 0.045 DBMET00253 | DBMET00253 | |
| 0.125 | 0.18 | 0.14 | Death-associated protein kinase 2 inhibitor | 0.14 0.132 DBMET00253 | DBMET00253 | |
| 0.045 | 0.1 | 0.072 | Protein kinase C beta inhibitor | 0.072 0.044 DBMET00253 | DBMET00253 | |
| 0.034 | 0.101 | 0.053 | Androgen agonist | 0.053 0.051 DBMET00253 | DBMET00253 | |
| 0.054 | 0.122 | 0.064 | MDM2 inhibitor | 0.064 0.059 DBMET00253 | DBMET00253 | |
| 0.086 | 0.16 | 0.111 | Transcription factor STAT6 inhibitor | 0.111 0.078 DBMET00253 | DBMET00253 | |
| 0.03 | 0.121 | 0.064 | Phosphofructokinase-1 inhibitor | 0.064 0.052 DBMET00253 | DBMET00253 | |
| 0.133 | 0.242 | 0.176 | DNA synthesis inhibitor | 0.176 0.16 DBMET00253 | DBMET00253 | |
| 0.063 | 0.186 | 0.12 | Alpha-N-acetylglucosaminidase inhibitor | 0.12 0.077 DBMET00253 | DBMET00253 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |